Please use this identifier to cite or link to this item:
http://hdl.handle.net/11054/1516| Title: | Remifentanil in labour. |
| Author: | Pillay, Monisha Frawley, Natasha Shaw, Michael Vincent, C. |
| Issue Date: | 2019 |
| Conference Name: | RANZCOG 2019 Annual Scientific Meeting |
| Conference Date: | October 13 - 16 |
| Conference Place: | Melbourne, Australia |
| Abstract: | Remifentanil has become a recent addition to pain management in the intrapartum period with Pethidine having been phased out at Ballarat Health Services. Whilst having been on the market for a while now, its introduction into the labour ward has been only recent due to the scarcity of high quality data in regards to its efficacy and side effect profile. With the recent RESPITE trial, data has shown that Remifenanil is indeed superior than the other opiod methods in labour in regards to analgesia and overall side effect profile. |
| URI: | http://hdl.handle.net/11054/1516 |
| Internal ID Number: | 01457 |
| Health Subject: | PAIN MANAGEMENT ANALGESIA INTRAPARTUM PERIOD LABOUR REMIFENTANIL |
| Type: | Conference Poster |
| Appears in Collections: | Research Output |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Remifentanil in Labour (Poster).pdf | Conference poster | 343.41 kB | Adobe PDF |  View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.